Request Call Back

Contact Us

Guillain Barre Syndrome
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Please explain what you believe GBS was caused by:

   * Please describe your case:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Guillain-Barre Syndrome

Guillain-Barre Syndrome Exposure Injury Lawsuits

Guillain-Barre Syndrome | Lawsuits, Lawyers | Bacterial Infection

Guillain Barre Syndrome (GBS) is a severe neurological disorder that may occur frequently in healthy individuals, either spontaneously or after certain infections. Guillain Barre Syndrome generally causes increasing weakness in the legs and arms that can be severe and require hospitalization. Guillain Barre Syndrome is an inflammatory disorder of the peripheral nerves.

Guillain-Barre Syndrome is a rare disorder; its incidence is approximately 1 to 2 cases in every 100,000 people per year. Men and women, young and old, are equally prone to contracting Guillain-Barre Syndrome. A small number of cases have been known to occur after medical procedures such as minor surgery.

The causes of Guillain-Barre Syndrome are not known; however, in about half of all cases, the onset of the Syndrome follows a viral or bacterial infection such as the following: gastrointestinal viral infection; infectious mononucleosis; viral hepatitis; campylobacteriosis (usually from eating undercooked poultry); porphyria (rare disease of red blood cells); flu or common cold.

The initial symptoms of Guillain-Barre Syndrome are usually numbness or tingling (paresthesia) in the toes and fingers with progressive weakness in the arms and legs over the next few days. Some patients experience paresthesia only in their toes and legs; others only experience symptoms on one side of the body.

The symptoms may stay in this stage, causing only mild difficulty in walking, requiring crutches or a walking stick. Sometimes the illness progresses, leading to complete paralysis of the arms and legs. About one quarter of the time, the paralysis continues up the chest and freezes the breathing muscles, leaving the patient dependent on a ventilator. If the swallowing muscles are also affected, a feeding tube may be needed.

Recently the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) reported they are investigating five reports of Guillain Barre Syndrome in teenagers who have taken Menactra, a new vaccine for meningitis.

Legal Help For Victims Affected By Guillain-Barre Syndrome

If you or a loved one has taken prescription medications to treat Meningitis and been diagnosed with Guillain Barre Syndrome, please fill out the form at the right for a free case evaluation by a qualified defective drug attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).


Guillain-Barre SyndromeRSS Feed

Illness Reported After H1N1 Vaccine

Nov 12, 2009 | Parker Waichman LLP
Less than 24 hours after being inoculated against the H1N1 Swine Flu, a young Virginia boy has come down with the dangerous, often debilitating Guillain-Barre syndrome, MSNBC is reporting.Jordan McFarland (14), is wheelchair-bound and developed severe headaches, spasms, and leg weakness, said MSNBC, and is expected to need to use a walker for up to six weeks and will have to undergo “extensive physical therapy,” following his shot. Jordon is not the only case, and this is not the...

Flu shot linked to risk

Nov 14, 2006 | Newsday
As federal health officials promoted the benefits of flu vaccinations yesterday, scientists in Canada warned about a rare but potent danger that sometimes occurs with the annual shots. Dr. David Juurlink of the University of Toronto reported in the Archives of Internal Medicine that the yearly flu shot is associated with a small but noteworthy risk. He said the shots can lead to hospitalization because of a neurological condition called Guillain-Barré syndrome. The potentially...

FDA and CDC Update Information on Menactra Meningococcal Vaccine and Guillain Barre Syndrome

Oct 20, 2006 |
The Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) are updating a previous alert to consumers and health care providers regarding reports of Guillain Barre Syndrome (GBS) following administration of Meningococcal Conjugate Vaccine A, C, Y, and W135 (trade name Menactra), manufactured by Sanofi Pasteur. In October 2005, FDA and CDC reported 5 cases of GBS following administration of Menactra ( GBS is...

Meningitis vaccine may have link to neurological disorder

Oct 10, 2005 | Dallas Morning News
Public health officials are investigating whether a new vaccine designed to help prevent meningitis, particularly among college students in dorms, could be linked to a rare neurological condition.The vaccine, called Menactra, helps protect against certain strains of meningococcal bacteria. Produced by Sanofi Pasteur, the vaccine was approved for use in January. While another vaccine was already on the market, doctors had hoped that the new formulation might offer longer immunity.Since Oct. 4,...

Menactra Vaccine May Have Tie to Brain Illness

Oct 3, 2005 |
The Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) are alerting consumers and health care providers that five reports of Guillain Barre Syndrome (GBS) followed administration of Menactra, a new vaccine against meningitis that is manufactured by Sanofi Pasteur.  It is not known yet whether these cases were caused by the vaccine or are coincidental.  Guillain Barre Syndrome (GDS) is a serious neurological disorder that can occur, often in healthy...

More Guillain-Barre Syndrome News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo